Jiali Li, MD, PhD

Additional Websites

• Carol Franc Buck Breast Care Center

Education

Tianjin Medical University, MD
University of Southern California, PhD
Stanford University, Postdoctoral Research
Residency, St. Mary's Medical Center, 2009
Fellowship, University of California San Francisco, 2012

Selected Publications

1. Li J, Rugo HS. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer. Breast Dis. 2011 Jan 1; 33(2):83-92.
   View on PubMed
2. Li J, Song W, Czerwinski DK, Varghese B, Uematsu S, Akira S, Krieg AM, Levy R. Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself. J Immunol. 2007 Aug 15; 179(4):2493-500.
   View on PubMed
3. Li J, Hu P, Khawli LA, Epstein AL. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. Cancer Res. 2003 Dec 1; 63(23):8384-92.
   View on PubMed
4. Li J, Hu P, Khawli LA, Epstein AL. LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors. J Immunother. 2003 Jul-Aug; 26(4):320-31.
   View on PubMed

View on UCSF Profiles